Yasuto Sakaguchi
Papers
1
Total Citations
6
H-Index
1
About
Dr. Yasuto Sakaguchi has made pioneering contributions to thoracic oncology, particularly at the intersection of immunotherapy and surgical intervention for non-small cell lung cancer (NSCLC). His research focuses on the emerging paradigm of salvage surgery following immune checkpoint inhibitor (ICI) therapy, a critical area for patients with initially unresectable disease. In his landmark 2024 study, Dr. Sakaguchi systematically investigated the characteristics and outcomes of patients undergoing salvage surgery after ICIs, addressing a previously unknown clinical frontier. This work, already garnering 6 citations shortly after publication, provides essential evidence that surgical resection can be safely and effectively performed following immunotherapy, potentially offering a curative pathway for patients who were once considered inoperable. By clarifying patient selection criteria and postoperative outcomes, Dr. Sakaguchi’s research bridges medical and surgical oncology, expanding treatment horizons for advanced NSCLC. His findings are shaping clinical decision-making and inspiring further investigation into multimodal approaches that integrate modern immunotherapies with traditional surgical techniques.
Research Focus
Key Achievements
Top Papers
- 1